Latest Building Supplies News

Stealth Group has reported record FY26 results, with EBITDA up 46.2% and net profit up 86.3% after its HBT acquisition. The next test is converting the enlarged network into recurring platform value while keeping leverage contained.

Big River Industries has carried its FY26 recovery into the new financial year, reporting 10.5% first-quarter revenue growth and a further lift in gross margin. The building-products group says its growth initiatives support above-market expansion, while a strategic review remains unresolved.

Big River Industries delivered a stronger FY26 despite subdued residential construction, lifting underlying EBITDA 8.4% and reducing gearing after its Johns Building Supplies acquisition. The company is targeting double-digit underlying EBITDA growth in FY27, while its strategic options review remains unresolved.

Big River Industries (ASX:BRI) reversed a $14.8 million loss in FY25 to a $4.9 million profit in FY26, driven by margin expansion and the acquisition of Johns Building Supplies. The group targets double-digit EBITDA growth in FY27 amid mixed market conditions.

NAOS Small Cap Opportunities Company Limited trimmed its after-tax loss to $6.6 million in FY26 while maintaining a 5-cent per share dividend. Despite portfolio underperformance against the ASX Small Ordinaries, the company’s shares rallied to trade at a premium to net tangible assets, with management optimistic about earnings momentum in FY27.

Stealth Group Holdings has posted record FY26 results with an 86% jump in net profit, driven by the transformative acquisition of Hardware & Building Traders. The company upgrades its FY28 sales target to $500 million, underpinned by expanded scale and integration synergies.

Big River Industries expects FY26 EBITDA growth around 8% despite Q4 revenue softness and forecasts double-digit growth for FY27, while initiating a strategic options review.

Stealth Group Holdings has posted record preliminary FY26 results, driven by strong organic growth and the transformative acquisition of Hardware & Building Traders (HBT). The company remains on track for its ambitious FY28 sales and EBITDA margin targets.

ReNerve has appointed J4 Biologics as a second manufacturer for its Empliq range to meet growing hospital approvals and market demand, strengthening its supply chain and scaling production capacity.

Big River Industries has posted a $1.4 million profit for the half-year ending December 2025, reversing a substantial loss from the previous year, while completing a strategic acquisition in Perth.

Big River Industries has successfully completed a $10 million entitlement offer, oversubscribed by shareholders, to partly fund its acquisition of Johns Building Supplies in Western Australia.

Big River Industries Ltd has announced a fully underwritten renounceable entitlement offer to raise approximately $10 million, aimed at funding its acquisition of John’s Building Supplies, a leading Western Australian building materials distributor. The offer opens on December 8 and closes on December 17, 2025.